1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with nicorandil in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikegaki, I; Sasaki, Y; Uchida, T; Yamamoto, Y | 1 |
| Fukumoto, Y; Inokuchi, K; Ito, A; Masuda, M; Matoba, T; Morita, S; Nishida, T; Shimokawa, H; Shiose, A | 1 |
| Arora, R; Jawad, E | 1 |
1 review(s) available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and nicorandil
| Article | Year |
|---|---|
Chronic stable angina pectoris.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetanilides; Angina Pectoris; Antihypertensive Agents; Benzazepines; Bosentan; Chronic Disease; Counterpulsation; Cyclic Nucleotide-Gated Cation Channels; Exercise Test; Heart Murmurs; Humans; Ivabradine; Myocardial Contraction; Myocardial Ischemia; Myocardial Revascularization; Myocardium; Nicorandil; Oxygen Consumption; Perhexiline; Piperazines; Protein Kinase Inhibitors; Ranolazine; Sulfonamides; Trimetazidine; Vasodilator Agents | 2008 |
2 other study(ies) available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and nicorandil
| Article | Year |
|---|---|
The protein kinase inhibitor fasudil protects against ischemic myocardial injury induced by endothelin-1 in the rabbit.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Cell Movement; Diltiazem; Electrocardiography; Endothelin-1; Enzyme Inhibitors; Heart Ventricles; Macrophages; Male; Microscopy; Myocardial Ischemia; Necrosis; Neutrophils; Nicorandil; Nifedipine; Papillary Muscles; Rabbits; Random Allocation; Vasodilator Agents | 2000 |
Usefulness of fasudil, a Rho-kinase inhibitor, to treat intractable severe coronary spasm after coronary artery bypass surgery.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Aged; Coronary Artery Bypass; Coronary Vasospasm; Diltiazem; Dose-Response Relationship, Drug; Drug Resistance; Female; Humans; Infusions, Intravenous; Intracellular Signaling Peptides and Proteins; Isosorbide Dinitrate; Male; Middle Aged; Nicorandil; Pain, Intractable; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; rho-Associated Kinases | 2004 |